New Cancer Technology Gives Investors a Shot in the Arm

Wall Street JournalNew Cancer Technology Gives Investors a Shot in the ArmWall Street JournalEarlier this month, Standard & Poor's released a report naming five cancer immunotherapy agents among its top 10 drug prospects for 2015, underscoring growing enthusiasm for the strategy. Drugs made the list for their likely blockbuster sales potential ...

Share this post